References
- IGISSIN N, ZATONSKIKH V, TELMANOVA Z, TULEBAEV R, MOORE M. Laryngeal Cancer: Epidemiology, Etiology, and Prevention: A Narrative Review. Iran J Public Health. 2023;52(11):2248–59.
- SITARU AM, FLONDOR D, DINU Ș, HORHAT ID, IFTODE OA, POENARU M., et al. Laryngeal malignancies – epidemiological data and particularities of the cases diagnosed in Western Romania (October 2016–July 2020). Rom J Morphol Embryol. 2022;63(1):153–60.
- SEO JH., KIM YD., PARK CS., HAN KD., JOO YH. Hypertension is associated with oral, laryngeal, and esophageal cancer: a nationwide population based study. Nat Sci Rep. 2020;10(1):10291.
- DE OLIVEIRA DE., BACCHI MM., MACARENCO RS., TAGLIARINI JV., CORDEIRO RC., BACCHI CE. Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma. Am J Clin Pathol. 2006;126(2):284–93.
- LEE LA., FANG TJ., LI HY., CHUANG HH., KANG CJ., CHANG KP., et al. Effects of Epstein-Barr Virus Infection on the Risk and Prognosis of Primary Laryngeal Squamous Cell Carcinoma: A Hospital-Based Case-Control Study in Taiwan. Cancers 2021;13(7):1741.
- PEREIRA DE LIMA MA., LIMA SILVA AD., SILVA DO NASCIMENTO FILHO AC., LIMA CORDEIRO T., DE SOUZA BEZERRA JP., BAROSSO ROCHA MA., et al. Epstein-Barr Virus-Associated Carcinoma of the Larynx: A Systematic Review with Meta-Analysis. Pathogens 2021;10(11):1429.
- ZENG Y., CHEN T. DNA methylation reprogramming during mammalian development. Genes 2019;10(4):257.
- BORSKY P., CHMELAROVA M., FIALA Z., PALICKA V., BERANEK M., KREMLACEK J., et al. Variation of selected genotoxic and epigenetic markers due to therapeutic exposure to PAHs and ultraviolet radiation. Bratisl Med J. 2020;121(8):558–64.
- LYKO F. The DNA methyltransferases family: a versatile toolkit for epigenetic regulation. Nat Rev Genet. 2018;19(2):81–92.
- WONG TS., GAO W., LI ZH., CHAN JYW., HO WK. Epigenetic Dysregulation in Laryngeal Squamous Cell Carcinoma. J Oncol. 2012;2012:739461.
- SAHA A., JHA HC., UPADHYAY SK., ROBERTSON ES. Epigenetic silencing of tumor suppressor genes during in vitro Epstein–Barr virus infection. PNAS 2015;112(37):E5199–207.
- TSAI CN., TSAI CL., TSE KP., CHANG HY., CHANG YS. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. PNAS 2002;99(15):10084–9.
- PENG H., CHEN Y., GONG P., CAI L., LYU X., JIANG Q., et al. Higher methylation intensity induced by EBV LMP1 via NF-kB/DNMT3b signaling contributes to silencing of PTEN gene. Oncotarget 2016;7(26):40025–37.
- SEO SY., KIM EO., JANG KL. Epstein-Barr virus latent membrane protein 1 suppresses the growth-inhibitory effect of retinoic acid by inhibiting retinoic acid receptor-β2 expression via DNA methylation. Cancer Lett. 2008;270(1):66–76.
- ZHANG L., WANG R., XIE Z. The roles of DNA methylation on the promotor of the Epstein–Barr virus (EBV) gene and the genome in patients with EBV-associated diseases. Appl Microbiol Biotechnol. 2022;106(12):4413–26.
- RAPADO-GONZALEZ O., MARTINEZ-REGLERO C., SALGADO-BARREIRA A., SANTOS MA., LOPEZ-LOPEZ R., DIAZ-LAGARES A., et al. Salivary DNA methylation as an epigenetic biomarker for head and neck cancer. Part II: A cancer risk meta-analysis. J Pers Med. 2021;11(7):606.
- FALCO M., TAMMARO C., TAKEUCHI T., COSSU AM., SCAFURO G., ZAPPAVIGNA S., et al. Overview on molecular biomarkers for laryngeal cancer: Looking for new answers to an old problem. Cancers 2022;14(7):1716.
- SKOCZYNSKI M., GOZDZICKA-JOZEFIAK A., KWASNIEWSKA A. Co-occurrence of human papillomavirus (HPV) in newborns and their parents. BMC Infect Dis. 2019;19(1):930.
- RYAN JL., FAN H., GLASER SL., SCHICHMAN SA., RAAB-TRAUB N., GULLEY ML. Epstein-Barr Virus Quantitation by Real-Time PCR Targeting Multiple Gene Segments. J Mol Diagn. 2004;6(4):378–85.
- IANCU IV., BOTEZATU A., PLEȘA A., HUICĂ I., FUDULU A., ALBULESCU A., et al. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer. Cancer Biomark. 2020;28(2):255–68.
- BOTEZATU A., IANCU IV., PLEȘA A., MANDA D., POPA O., BOSTAN M., et al. Methylation of tumor suppressor genes associated with tyroid cancer. Cancer Biomark. 2019;25(1):53–65.
- FACKLER MJ., MCVEIGH M., MEHROTRA J., BLUM MA., LANGE J., LAPIDES A. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res. 2004;64(13):4442–52.
- NISHIYAMA A., NAKANISHI M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37(11):1012–27.
- BOYNE DJ., O'SULLIVAN DE., OLIJ BF., KING WD., FRIENDENREICH CM., BRENNER DR. Physical activity, global DNA methylation, and breast cancer risk: A systematic literature review and Meta-analysis. Cancer Epidemiol Biomarkers Prev. 2018;27(11):1320–31.
- STEMBALSKA A., LESZCZYNSKI P., GIL J., RAMSEY D., PITALA G., MACIEJCZYK A., et al. Global DNA methylation status in laryngeal cancer. Head Neck 2014;36(3):419–24.
- FERRAGUTI G., TERRACINA S., PETRELLA C., GRECO A., MINNI A., LUCARELLI M., et al. Alcohol and head and neck cancer: Updates on the role of oxidative stress, genetic, epigenetics, oral microbiota, antioxidants and alkylating agents. Antioxidants 2022;11(1):145.
- CUI J., ZHENG L., ZHANG Y., XUE M. Bioinformatics analysis of DNMT1 expression and its role in head and neck squamous cell carcinoma prognosis. Nat Sci Rep. 2021;11(1):2267.
- WONG TS., GAO W., LI ZH., CHAN JYW., HO WK. Epigenetic dysregulation in laryngeal squamous cell carcinoma. J Oncol. 2012;2012:739461.
- LIU Y., ZHOU ZT., HE QB., JIANG WW. DAPK promoter hypermethylation in tissues and body fluids of oral precancer patients. Med Oncol. 2012;29(2):729–33.
- STRZELCZYK JK., KRAKOWCZYK L., OWCZAREK AJ. Methylation status of SFRP1, SFRP2, RASSF1A, RARβ and DAPK1 genes in patients with oral squamous cell carcinoma. Arch Oral Biol. 2019;98:265–72.
- PALUSZCZAK J., HEMMERLING D., KOSTRZEWSKA-POCZEKAJ M., JARMUZ-SZYMCZAK M., GRENMAN R., WIERZBICKA M., et al. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas. J Oral Pathol Med. 2014;43(9):652–57.
- PALUSZCZAK J., WISNIEWSKA D., KOSTRZEWSKA-POCZEKA M., KIWERSKA K., GRENMAN R., MIELCAREK-KUCHTA D., et al. Prognostic significance of the methylation of Wnt pathway antagonists—CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling — ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas. Clin Oral Invest. 2017;21(5):1777–88.
- LIU P., YANG F., ZHANG L., HU Y., CHEN B., WANG J., et al. Emerging role of different DNA methyltransferases in the pathogenesis of cancer. Front Pharmacol. 2022;13:958146.
- CHEN WC., CHEN MF., LIN PY. Significance of DNMT3b in oral cancer. PLoS One 2014;9(3):e89956.
- LEONG MML., LUNG ML. The Impact of Epstein-Barr Virus Infection on Epigenetic Regulation of Host Cell Gene Expression in Epithelial and Lymphocytic Malignancies. Front Oncol. 2021;11: 629780.
- HUTAJALU SH., INDRASARI SR., INDRAWATI LPL., HARIJADI A., DUIN S., HARYANA SM., et al. Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population. Mol Cancer 2011;10:48.
- YANG X., DAI W., KWONG DLW., SZETO CYY., WONG EHW., TONG NG W., et al. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting. Int J Cancer 2015;136(4):E127–35.